Astellas Pharma

要求内容

Strategy / Operations

概要

Source: Barclays 2025 Review of Shareholder Activism. Farallon Capital Management built 3.0% stake in Astellas Pharma (Healthcare). Objective: Strategy / Operations.

結果詳細

Barclays 2025 Review: 2/12/2025 | Market Cap: $16,972M | Activist stake: 3.0%

戦術

詳細コンテンツは準備中です。